• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球、区域和国家神经障碍负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

出版信息

Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.

DOI:10.1016/S1474-4422(18)30499-X
PMID:30879893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6459001/
Abstract

BACKGROUND

Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders.

METHODS

We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs; the sum of years of life lost [YLLs] and years lived with disability [YLDs]) by age and sex for 15 neurological disorder categories (tetanus, meningitis, encephalitis, stroke, brain and other CNS cancers, traumatic brain injury, spinal cord injury, Alzheimer's disease and other dementias, Parkinson's disease, multiple sclerosis, motor neuron diseases, idiopathic epilepsy, migraine, tension-type headache, and a residual category for other less common neurological disorders) in 195 countries from 1990 to 2016. DisMod-MR 2.1, a Bayesian meta-regression tool, was the main method of estimation of prevalence and incidence, and the Cause of Death Ensemble model (CODEm) was used for mortality estimation. We quantified the contribution of 84 risks and combinations of risk to the disease estimates for the 15 neurological disorder categories using the GBD comparative risk assessment approach.

FINDINGS

Globally, in 2016, neurological disorders were the leading cause of DALYs (276 million [95% UI 247-308]) and second leading cause of deaths (9·0 million [8·8-9·4]). The absolute number of deaths and DALYs from all neurological disorders combined increased (deaths by 39% [34-44] and DALYs by 15% [9-21]) whereas their age-standardised rates decreased (deaths by 28% [26-30] and DALYs by 27% [24-31]) between 1990 and 2016. The only neurological disorders that had a decrease in rates and absolute numbers of deaths and DALYs were tetanus, meningitis, and encephalitis. The four largest contributors of neurological DALYs were stroke (42·2% [38·6-46·1]), migraine (16·3% [11·7-20·8]), Alzheimer's and other dementias (10·4% [9·0-12·1]), and meningitis (7·9% [6·6-10·4]). For the combined neurological disorders, age-standardised DALY rates were significantly higher in males than in females (male-to-female ratio 1·12 [1·05-1·20]), but migraine, multiple sclerosis, and tension-type headache were more common and caused more burden in females, with male-to-female ratios of less than 0·7. The 84 risks quantified in GBD explain less than 10% of neurological disorder DALY burdens, except stroke, for which 88·8% (86·5-90·9) of DALYs are attributable to risk factors, and to a lesser extent Alzheimer's disease and other dementias (22·3% [11·8-35·1] of DALYs are risk attributable) and idiopathic epilepsy (14·1% [10·8-17·5] of DALYs are risk attributable).

INTERPRETATION

Globally, the burden of neurological disorders, as measured by the absolute number of DALYs, continues to increase. As populations are growing and ageing, and the prevalence of major disabling neurological disorders steeply increases with age, governments will face increasing demand for treatment, rehabilitation, and support services for neurological disorders. The scarcity of established modifiable risks for most of the neurological burden demonstrates that new knowledge is required to develop effective prevention and treatment strategies.

FUNDING

Bill & Melinda Gates Foundation.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d793/6459001/fcea2793d797/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d793/6459001/4f101d67e54d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d793/6459001/7ef4be97ab03/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d793/6459001/fcea2793d797/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d793/6459001/4f101d67e54d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d793/6459001/7ef4be97ab03/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d793/6459001/fcea2793d797/gr3.jpg
摘要

背景

神经系统疾病日益成为全球范围内主要的死亡和致残原因。本分析来自全球疾病、伤害和危险因素研究(GBD)2016 年,旨在提供最全面和最新的全球、区域和国家神经系统疾病负担估计。

方法

我们通过年龄和性别估计了 15 种神经系统疾病类别(破伤风、脑膜炎、脑炎、中风、脑和中枢神经系统癌症、创伤性脑损伤、脊髓损伤、阿尔茨海默病和其他痴呆、帕金森病、多发性硬化症、运动神经元疾病、特发性癫痫、偏头痛、紧张型头痛以及其他较不常见的神经系统疾病的残余类别)的患病率、发病率、死亡率和伤残调整生命年(DALYs;生命损失年[YLL]和残疾生活年[YLD]之和)。DisMod-MR 2.1 是患病率和发病率的主要估计方法,死因综合模型(CODEm)用于死亡率估计。我们使用 GBD 比较风险评估方法,对 15 种神经系统疾病类别疾病的 84 种风险和风险组合的贡献进行了量化。

结果

在全球范围内,2016 年神经系统疾病是 DALYs(2.76 亿[95%UI 2.47-3.08])的主要原因,也是死亡的第二大原因(900 万[8.8-9.4])。所有神经系统疾病的死亡人数和 DALYs 绝对值都有所增加(死亡人数增加 39%[34-44],DALYs 增加 15%[9-21]),而其年龄标准化率却有所下降(死亡人数下降 28%[26-30],DALYs 下降 27%[24-31])。在 1990 年至 2016 年期间,死亡率和 DALYs 绝对数量下降的唯一神经系统疾病是破伤风、脑膜炎和脑炎。DALYs 中四个最大的贡献者是中风(42.2%[38.6-46.1])、偏头痛(16.3%[11.7-20.8])、阿尔茨海默病和其他痴呆(10.4%[9.0-12.1])和脑膜炎(7.9%[6.6-10.4])。对于合并的神经系统疾病,男性的年龄标准化 DALY 率明显高于女性(男女比 1.12[1.05-1.20]),但偏头痛、多发性硬化症和紧张型头痛更为常见,且女性的负担更大,男女比低于 0.7。GBD 中量化的 84 种风险,除中风外,对神经系统疾病的 DALY 负担的解释不到 10%,其中中风 88.8%(86.5-90.9)的 DALYs 归因于风险因素,而阿尔茨海默病和其他痴呆(22.3%[11.8-35.1]的 DALYs 归因于风险)和特发性癫痫(14.1%[10.8-17.5]的 DALYs 归因于风险)的情况则稍好一些。

解释

在全球范围内,以 DALYs 绝对值衡量,神经系统疾病的负担仍在继续增加。随着人口的增长和老龄化,以及主要致残性神经系统疾病的患病率随年龄急剧上升,各国政府将面临对神经系统疾病治疗、康复和支持服务需求的增加。大多数神经系统疾病负担的既定可改变风险稀缺,这表明需要新的知识来制定有效的预防和治疗策略。

资金

比尔和梅琳达·盖茨基金会。

相似文献

1
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家神经障碍负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.
2
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家神经系统疾病负担:全球疾病负担研究2015的系统分析
Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17.
3
The burden of neurological conditions in north Africa and the Middle East, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.北非和中东地区神经疾病负担,1990-2019 年:2019 年全球疾病负担研究的系统分析。
Lancet Glob Health. 2024 Jun;12(6):e960-e982. doi: 10.1016/S2214-109X(24)00093-7. Epub 2024 Apr 8.
4
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
5
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.全球、地区和国家慢性阻塞性肺疾病和哮喘的死亡、患病率、残疾调整生命年以及与残疾相关的生命年,1990-2015 年:2015 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16.
6
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家发病率、患病率以及 195 个国家和地区 1990 年至 2016 年 328 种疾病和伤害导致的残疾年数:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
7
The burden of common neurological disorders in Asia: insights from the Global Burden of Disease Study (1990-2021).亚洲常见神经疾病的负担:全球疾病负担研究(1990 - 2021年)的见解
J Neurol. 2025 Apr 10;272(5):333. doi: 10.1007/s00415-025-13074-4.
8
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
9
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
10
The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.欧洲神经疾病负担:2017 年全球疾病负担研究分析。
Lancet Public Health. 2020 Oct;5(10):e551-e567. doi: 10.1016/S2468-2667(20)30190-0.

引用本文的文献

1
Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases.间充质干细胞在神经退行性疾病中的治疗潜力。
World J Stem Cells. 2025 Aug 26;17(8):107717. doi: 10.4252/wjsc.v17.i8.107717.
2
Redirection of Care after Traumatic Brain Injury in Intensive Care: Sex and Social Determinants of Health.重症监护中创伤性脑损伤后的护理转向:性别与健康的社会决定因素
Neurotrauma Rep. 2025 Jul 22;6(1):569-577. doi: 10.1177/08977151251360617. eCollection 2025.
3
Education Research: ANSWER: A Multimodal Teaching Intervention for Neurology Undergraduate Medical Education: A Randomized Crossover Control Trial.

本文引用的文献

1
Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家脑和其他中枢神经系统癌症负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Apr;18(4):376-393. doi: 10.1016/S1474-4422(18)30468-X. Epub 2019 Feb 21.
2
Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家癫痫负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Apr;18(4):357-375. doi: 10.1016/S1474-4422(18)30454-X. Epub 2019 Feb 14.
3
教育研究:答案:一种用于神经病学本科医学教育的多模式教学干预:一项随机交叉对照试验。
Neurol Educ. 2025 Sep 8;4(3):e200238. doi: 10.1212/NE9.0000000000200238. eCollection 2025 Sep.
4
Digital speech assessments and machine learning for differentiation of neurodegenerative diseases.用于神经退行性疾病鉴别的数字语音评估与机器学习
Clin Park Relat Disord. 2025 Aug 28;13:100389. doi: 10.1016/j.prdoa.2025.100389. eCollection 2025.
5
Exploring the Emerging Role of Stem Cell Therapy in Neurodegenerative Diseases and Spinal Cord Injury: A Narrative Review.探索干细胞疗法在神经退行性疾病和脊髓损伤中的新兴作用:一项叙述性综述
Cureus. 2025 Aug 8;17(8):e89629. doi: 10.7759/cureus.89629. eCollection 2025 Aug.
6
Pain Management Strategies and Adverse Effects of Opioids in Patients with Neurotrauma with Acute and Chronic Pain.神经创伤伴急慢性疼痛患者的疼痛管理策略及阿片类药物的不良反应
Neurotrauma Rep. 2025 Aug 19;6(1):686-699. doi: 10.1177/08977151251365585. eCollection 2025.
7
Analysis of six CYP450 genetic variants regarding the response to cannabidiol combined with anticonvulsant medication in mexican patients with drug-resistant epilepsy.对墨西哥耐药性癫痫患者中六种细胞色素P450基因变异与大麻二酚联合抗惊厥药物反应的分析。
Front Pharmacol. 2025 Aug 21;16:1626054. doi: 10.3389/fphar.2025.1626054. eCollection 2025.
8
Identification of Common Genes for Neuropathic Pain and Parkinson's Disease Based on Bioinformatics Analysis and Their Potential Value in the Diagnosis of Neuropathic Pain.基于生物信息学分析的神经性疼痛与帕金森病共同基因的鉴定及其在神经性疼痛诊断中的潜在价值
J Pain Res. 2025 Sep 1;18:4483-4495. doi: 10.2147/JPR.S532016. eCollection 2025.
9
Impacts of mitochondrial dysfunction on axonal microtubule bundles as a potential mechanism of neurodegeneration.线粒体功能障碍对轴突微管束的影响作为神经退行性变的一种潜在机制。
Front Neurosci. 2025 Aug 19;19:1631752. doi: 10.3389/fnins.2025.1631752. eCollection 2025.
10
Association Between Magnesium Intake and Migraine Among Pre and Postmenopausal Women: A Cross-Sectional Study.绝经前后女性镁摄入量与偏头痛之间的关联:一项横断面研究。
Int J Womens Health. 2025 Aug 29;17:2747-2758. doi: 10.2147/IJWH.S536420. eCollection 2025.
Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
全球、区域和国家多发性硬化症负担 1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Mar;18(3):269-285. doi: 10.1016/S1474-4422(18)30443-5. Epub 2019 Jan 21.
4
Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家脑膜炎负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Dec;17(12):1061-1082. doi: 10.1016/S1474-4422(18)30387-9. Epub 2018 Nov 13.
5
Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家创伤性脑损伤和脊髓损伤负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Jan;18(1):56-87. doi: 10.1016/S1474-4422(18)30415-0. Epub 2018 Nov 26.
6
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家阿尔茨海默病及其他类型痴呆症负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Jan;18(1):88-106. doi: 10.1016/S1474-4422(18)30403-4. Epub 2018 Nov 26.
7
Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家运动神经元疾病负担 1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Dec;17(12):1083-1097. doi: 10.1016/S1474-4422(18)30404-6. Epub 2018 Nov 5.
8
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家偏头痛和紧张型头痛负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):954-976. doi: 10.1016/S1474-4422(18)30322-3.
9
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家帕金森病负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
10
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家神经系统疾病负担:全球疾病负担研究2015的系统分析
Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17.